A Global CDMO Fully Dedicated To Cell And Gene Therapies

Successfully bringing an advanced therapeutic to market requires expertise in clinical and commercial manufacturing as well as state-of-the-art-facilities that deliver quality services. A global CDMO with years of experience in GMP manufacturing of allogeneic and autologous therapies, T-cells, stem cells, iPSCs, and more can help deliver life-saving treatments to patients in need.

With facilities on three continents and experience in regulatory compliance, Minaris Regenerative Medicine is poised to meet your project needs and support the goal of improving patients’ lives. Explore how Minaris’ clinical and commercial manufacturing solutions and comprehensive quality systems can help you overcome challenges on the road to approval.